Ischemic Stroke
Conditions
Interventions
Treatment group:1. Acupoint: Shenque (CV8).
2. Equipment: Medicinal cake, moxibustion box, strap, flame gun, smokeless moxa stick (diameter 1.8 cm, length 20 cm), metal tray.
3. Procedure:
(1
(2) Place the moxibustion box over the Shenque point and secure it with a strap
(3) Insert the smokeless moxa stick into the fixed holder on the moxibustion box, ensuring the bottom end of the stick is positioned 2–3 cm above the bottom of the box
(4) Light the moxa stick
during the procedure, continuously adjust the distance between the burning end of the stick and the bottom of the box, and closely monitor to prevent falling embers from causing burns or damaging equi
(5) Each treatment session lasts 60 minutes
(6) After treatment, clean the application site, assist the patient in adjusting clothing, and have them rest in a comfortable position for 5–10 minutes
(7) After the patient returns to the ward, organize and inventory all used materials, and maintain a clean environment in the moxibustion room.
4. Treatment regimen: Continuous treatment for 7 days,
Control group:Routine treatment
Sponsors
Wuxi No.2 People's Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Meeting the above diagnostic criteria of traditional Chinese and Western medicine; 2. Aged 20–80 years, regardless of gender; 3. Disease duration between 2 weeks and 6 months; 4. With neurological impairment, clear consciousness, stable clinical signs, and able to cooperate with all assessments; 5. Provided informed consent and signed the informed consent form personally.
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the diagnostic criteria or inclusion criteria; 2. Those with severe disturbance of consciousness, severe dementia, speech impairment, or other conditions preventing communication or description of symptoms; 3. Those with severe concomitant dysfunction of the heart, lung, liver, kidney, or other vital organs, or those in the acute phase of other serious diseases; 4. Those unable to comply with study requirements due to poor adherence; 5. Those allergic to moxibustion, or fearful of or intolerant to acupuncture and moxibustion; 6. Those currently participating in other clinical trials; 7. Those lost to follow-up during treatment. Anyone meeting any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebral circulation indicators;NIHSS scale;ADL Scale (Modified Barthel Index); | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin-1ß;Interleukin-6;Nuclear Factor Kappa B;Endothelin-1;Endothelial Nitric Oxide Synthase; | — |
Countries
China
Contacts
Public ContactShen Cuicui
Wuxi No.2 People's Hospital
Outcome results
None listed